Lung Cancer – 1986
DOI:
https://doi.org/10.32635/2176-9745.RBC.1986v32n2.3249Palabras clave:
Neoplasias Pulmonares/epidemiología, Neoplasias Pulmonares/diagnóstico, Tamizaje MasivoResumen
In the United States, lung cancer is the most frequent site of cancer in men (22%) and tied for the third most common site (uterus) in women based on the 1986 estimated cancer incidence. It is the most frequent cause of cancer death in men (35%) and 1986 estimates suggest it is the most frequent cause of cancer death in women (19%), shghtly greater than breast cancer (18%). Although the cause of lung cancer is almost certainly muitifactorial, the most importante factor is clearly tobacco use. There is a very high frequency of this malignant tumour in smokers; in addition, there appears to be a passive effect with an increased incidence in the occupants of households exposed to smokers. Asbestos and other occupational materials may also play a part in this disease.
Descargas
Citas
Cancer Statistics 1986. CA - A Cancer Journal for Clinicians. 36:9-25. DOI: https://doi.org/10.3322/canjclin.36.1.9
Carr DT, Lukeman SM. Classification of lung cancer. Cancer Bulletin 1980;32: 77-85.
Sanderson O. Lung cancer screening. The Mayo Study. Chest 1986; 89: 324S. DOI: https://doi.org/10.1378/chest.89.4_Supplement.324S
Martini N. Results of the Memorial Sloan-Kettering study in screening for early lung cancer.
Tockman MS. Survival and mortality from lung cancer in a screened popuiation. The John Hopkins Study. Chest 1986; 89:324S-3255. DOI: https://doi.org/10.1378/chest.89.4_Supplement.324S-a
Anderson P0. Scintigraphic evaluation of patients with lung cancer. Chest 1986; 89: 245S-24. DOI: https://doi.org/10.1378/chest.89.4.245S
Heitzman ER. The role of computed tomography in the diagnosis and management of lung cancer. Chest 1986; 89: 237S-241S. DOI: https://doi.org/10.1378/chest.89.4_Supplement.237S
Gamsu G. Magnetic resonance imaging in lung cancer. Chest 1986; 89: 242S-244S. DOI: https://doi.org/10.1378/chest.89.4_Supplement.242S
Poon PY, Bronskiil MJ, Henkelman RM, et al. Magnetic resonance imaging and computed tomography in detecting mediastinal lymph node metastases from bronchogenic carcinona. Submitted to Radiology (May, 1986).
Tao LC. Transthoracic fine-needie aspiration biopsy. Cytomorphologic interpretation and its histologic basis. Chest 1986; 328S-330S. DOI: https://doi.org/10.1378/chest.89.4_Supplement.328S
Weisbrod GL. Transthoracic percutaneous flne needle aspiration biopsy. Chest 1986; 330S-331S. DOI: https://doi.org/10.1378/chest.89.4_Supplement.330S
Wang KP, Terry P8. Transbronchial needle aspiration in the diagnosis and staging of bronchogenic carcinoma. Am Rev Respir Dis 1983; 127: 344-347.
Mountain CF. A new interriatiorial staging system for lung cancer. Chest 1986; 89: 2255-2335. DOI: https://doi.org/10.1378/chest.89.4.225S
Campling 8, Quirt 1, DeBoer G, Feld R, Shepherd FA Evans WK. Bone marrow examination in the staging of small cell lung cancer: is it really necessary? Annals of Int Mcd (1986) (in press). DOI: https://doi.org/10.7326/0003-4819-105-4-508
Ginsberg RJ. The Lung Cancer Study Group experience. Chest 1986; 89:342S. DOI: https://doi.org/10.1378/chest.89.4_Supplement.342S
Martini N, Fiehinger BJ, Zaman MB, et al. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg 1983; 198: 386-397. DOI: https://doi.org/10.1097/00000658-198309000-00015
Ginsberg RJ, Hill LD, Eagan RT et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983; 86: 654-658. DOI: https://doi.org/10.1016/S0022-5223(19)39080-4
Feld R, Rubinstein LV, Weisenberger TH and the Lung Cancer Study Group. Sites of recurrence in resected stage 1 non-small cell lung cancer. A guide for future studies. J Clin Oncol 1984; 2:1352-1358. DOI: https://doi.org/10.1200/JCO.1984.2.12.1352
Mulshine JL, Glatstein E, Ruckdeschel JC. Treatment of non-small cell lung cancer. J Clin Oncol (1986) (in press). DOI: https://doi.org/10.1200/JCO.1986.4.11.1704
Petrovich Z, Stanley K, Coy JD et al. Radiotherapy in the management of locally advanced lung cancer of all cell types: Final report of randomized trial. Cancer 1981; 48: 1335-1340. DOI: https://doi.org/10.1002/1097-0142(19810915)48:6<1335::AID-CNCR2820480614>3.0.CO;2-S
Perez CA. Non-small cell carcinoma of the lung: Dose-time parameters. Cancer Treat Sympos 1985; 2:131-142.
Paulson DL. Carcinoma in the superior pulmonary sulcus. J Thorac Cardiovasc Surg 1975; 70: 1095-1104. DOI: https://doi.org/10.1016/S0022-5223(19)39657-6
Holmes EC. Surgical adjuvant therapy of non-small cell lung cancer. Chest 1986; 89: 295S-3005. DOI: https://doi.org/10.1378/chest.89.4.295S
Hilaris BS, Nori D, Beattie ES et al. Value of perioperative brachytherapy in the management of non-oat celi carcinoma of the lung. int J Radiat Oncol Biol 6101 1983; 9: 1161-1166. DOI: https://doi.org/10.1016/0360-3016(83)90174-8
Nag S. Brachytherapy for lung cancer. Cancer Treat Symp 1985; 2:49-56.
Cortere DA. Endobronchial management of lung cancer. Chest 1986; 234S-2365. DOI: https://doi.org/10.1378/chest.89.4.234S
Klastersky J. Non surgical combined modality therapies in non-small cell lung cancer. Chest 1986; 89: 289S-294S. DOI: https://doi.org/10.1378/chest.89.4_Supplement.289S
Woods RL, Levi JA, Page J, et al. Non small cell cancer: A randomized comparison of chemotherapy with no chemotherapy (Abstract) Proc Am Soc Clin 0ncoi 1985; 4 (C-691) 177.
Eagan RT, Lee RE, Frytak S. et al. Randomized trial of thoracic irradiation plus combination chemotherapy for unresectable adenocarcinoma and large cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1979; 5: 1401-1405. DOI: https://doi.org/10.1016/0360-3016(79)90678-3
Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 1973; (Part 3) 4(2): 31-42.
Hyde L, Wolfe J, McCracken S, Yesner R. Natural course of inoperable lung cancer. Chest 1973; 64: 309-312. DOI: https://doi.org/10.1378/chest.64.3.309
Fox W, Scadding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celied carcinoma of the bronchus: ten-year follow-up. Lancet 1973; 2:63-65. DOI: https://doi.org/10.1016/S0140-6736(73)93260-1
Bergsagel DE, Jenkin RDT, Pringle JR, et al. Lung Cancer: Clinical trial of radiotherapy aiorie vs radiotherapy plus cyclophosphamide. Cancer 1972; 30: 621-627. DOI: https://doi.org/10.1002/1097-0142(197209)30:3<621::AID-CNCR2820300305>3.0.CO;2-0
Host H. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma. Cancer Chemother Rep 1973; 4: 161-164.
Medical Research Council Lung Cancer Working Parsy: Radiotherapy alone or with chemotherapy in the treatment of small cell carcinoma of the lung: the results at 36 months. Br J Cancer 1981; 44: 611-617. DOI: https://doi.org/10.1038/bjc.1981.245
Bieehen NM. Radiotherapy for small cell lung cancer. Chest 1986; 89: 2685-2765. DOI: https://doi.org/10.1378/chest.89.4.268S
Williams C, Alexander M, Glatstein EJ, Daniels JR. Role of radiation therapy in combination with chemotherapy in extensive oat ccli cancer of the lung: a randomized study. Cancer Treat Rep 1977; 61: 1427-1431.
Morstyn G, lhde DC, Lichter AS, et al. Small cell lung cancer 1973-1983: Early progress and recent obstacies. Int J Radiat Oncol Biol Phys 1984; 10: 51 5-539. DOI: https://doi.org/10.1016/0360-3016(84)90032-4
lhde D. Current status of therapy for small cell carcinoma of the lung. Cancer 1984; 54:2722-2728. DOI: https://doi.org/10.1002/1097-0142(19841201)54:2+<2722::AID-CNCR2820541419>3.0.CO;2-P
Shank B, Scher Hi. Controversies in the treatment of small cell carcinoma of the lung. Cancer investigation 1985; 3: 367-387. DOI: https://doi.org/10.3109/07357908509039798
Livingston RB. Current chemotherapy of small cell lung cancer. Chest 1986; 89: 2485-2635. DOI: https://doi.org/10.1378/chest.89.4.258S
Cohen MH, Craven PJ, Fossieck BE, et al. intensive chemotherapy of smaii ceil bronchogenic carcinoma. Cancer Treat Rep 1977; 61: 349-354.
Rosen S, Mulshine J, Cuttitta F et al. Analysis of human small cell lung cancer differentiation antigens using a panel of cat monoclonal antidodies. Cancer Res 1984; 44: 2052-2061.
Goldie JH, Coidman AJ, Gudauskas GA. Rationale for the use of alternating non-cross resistant chemotherapy. Cancer Treat Rep 1982; 66: 439-449.
Bonadonna G, Viviani S, 8onfante V et al. Alternating chemotherapy with MOPP/ABVD in Hodgkin'sdisease: Updated results. 1984; (Abstr) Proc Am Soc Clin Oricol 3:254.
Elliot J, 0steriind K, Hansen H. Cyclic alternating "non-cross resistant" chemotherapy in the management of small cell anaplastic carcinoma of the lung. Cancer Treat Rev (1985).
Evans WK, Murray NJ, Feld R, et al. Canadian multicenter randomized trial comparing standard (SD) and alternating (A) combination chemotherapy in extensive small cell lung cancer (SCLC) (Abstract) Proc Am Soc Clin Oncol 1986.
Feld R, Evans WK, DeBoer G et al. Combined modality induction therapy without maintenarice chemotherapy for small cell carcinoma of the lung. J Clin Oncol 1984; 2: 294-304. DOI: https://doi.org/10.1200/JCO.1984.2.4.294
Woods RL, Levi JA. Chemotherapy for small cell lung cancer (SCLC): a randomized study of maintenance therapy with cyclophosphamide, adriamycin and vincristine (CAV) after remission induction with cis-platinum (CIS-DDP), VP-16-213 and radiotherapy (Abstract) Proc Am Soc Clin Oncol 1984; 3:214.
Shields TW. Surgery of small cell lung cancer. Chest 1986; 89: 2655-267S. DOI: https://doi.org/10.1378/chest.89.4_Supplement.264S
Cohen MH, Chretien PB, lhde DC et al. Thymosin fraction V and intensive combination chemotherapy: Prolonging the survival of patients with small cell lung cancer. JAMA 1979; 241: 1813-1815. DOI: https://doi.org/10.1001/jama.241.17.1813
Carney DN. Recent advance in the biology of small cell lung cancer. Chest 1986; 89: 2535-257S. DOI: https://doi.org/10.1378/chest.89.4_Supplement.253S
